Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
are obese, and about 1 in 13 are severely obese
Potential limitations The study did have some limitations, noted researcher Etminan
The medication is administered once weekly via subcutaneous injection, with doses typically initiated at 2.5 mg once weekly for 4 weeks, then escalated (e.g., to 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg) based on response and tolerability as per the SmPC
73 HurtigM.GreenS
Lancet 402(10401):529544 Papageorgiou M, Biver E (2023) Bone consequences of intentional weight loss in overweight or obese patients
US$ 22.01
US$ 21.26
US$ 28.24
US$ 27.50
US$ 29.92
